Alice K. Jacobs, MD
Boston University School of Medicine
Dept of Medicine
Cardiovascular Medicine

MD, Saint Louis University

A professor of medicine and the Director of the Cardiac Catheterization Laboratory and Interventional Cardiology at Boston Medical Center, has been very involved in the American Heart Association. On a national level at the AHA, she is currently President -Elect, chair of the Professional Education Committee, a member of the Science Advisory Coordinating Committee and chair of the Council on Clinical Cardiology Program Committee. She is also involved in local AHA activities and currently serves as President of the Northeast Affiliate. In addition, Dr. Jacobs plays an active role in the American College of Cardiology. She has been a member of several ACC writing groups establishing training criteria in interventional cardiology, assessing and maintaining competence in interventional cardiology and updating guidelines for the performance of percutaneous coronary intervention. In addition, she is a member of the American Board of Internal Medicine Interventional Cardiology Test Committee and the ACC/AHA Task Force on Practice Guidelines. Dr. Jacobs' major research activities are in the area of invasive cardiology and revascularization strategies. Currently she is the site principal investigator of several multi-center trials including the NHLBI funded BARI 2-D, SHOCK, and OAT trials and the NHLBI Dynamic Registry. She is also active in the area of heart disease in women and has evaluated the acute and long-term outcomes of percutaneous coronary intervention in women in comparison to men.

Expertise includes: Interventional Cardiology; Coronary revascularization; Sex-based differences in cardiovascular disease.

2011-2011 LUMEN Conference: Recognition for advancing the care of patients with STEMI

A Clinical Evaluation of Absorb BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment...
08/22/2013 - 12/31/2018 (PI)
Abbott Laboratories

A prospective, multi-center, randomized, double-blind trial to assess the effectiveness and safety of 12 versus 30 months of dual antiplatelet therapy (DAPT) in subjects undergoing percutaneous c
05/01/2010 - 04/30/2015 (PI)
Harvard Clinical Research Institute

Gravitas: Gauging Responsivness with a Verify Now Assay-Impact on Thrombsis and Safety
10/01/2008 - 09/30/2012 (PI)

Xience V Everolimus Eluting Coronary Stent System Post-Approval Study (EECSS)
09/01/2008 - 05/31/2012 (PI)
Abbott Laboratories

Tilarginine Acetate Injection in a Randomized International Study in Unstable AMI Patients / Cardiogenic Shock
07/01/2005 - 06/30/2007 (PI)

D.E.S. Cover Registry
04/13/2005 - 04/12/2007 (PI)
Cordis Corporation

The GUARD Trial Saphenous Vein Graft Intervention Using AngioGuard for Reduction of Distal Embolization
11/29/2000 - 12/31/2005 (PI)
Cordis Corporation

Clopidogrel for Reduction of Events During Observation (CREDO)
08/25/2000 - 08/31/2001 (PI)
Sanofi Pharmaceuticals Inc (from Cleveland Clinic Foundation) Bristol-Myers Squibb

XaNADU PCI Pilot Trial
01/22/2001 - 05/31/2001 (PI)
Duke University

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study
06/01/2015 - 05/31/2018 (PI)
Duke University Astrazeneca Pharmace

SILVER-AMI : Risk Stratification in Older Persons with Acute Myocardial Infarction
06/01/2013 - 05/31/2018 (PI)
Yale University NIH-NHLBI

08/30/2006 - 06/30/2014 (PI)
Harvard Clinical Research Institute DPH

VIRGO study
04/01/2009 - 05/01/2014 (PI)
Yale University NIH-NHLBI
R01 HL081153

Occluded Artery Trial (OAT)
02/01/2001 - 12/31/2010 (PI)
New York University DHHS
U01 HL62509

Bari 2 Diabetes (BARI 2D) Data Coordinating Center
01/01/2001 - 09/30/2010 (PI)
University of Pittsburgh DHHS
5 U01 HL61744-03

FREEDOM (Future Revascularization Evaluation in patients with Diabetes mellitus: Optimal management
06/22/2006 - 12/31/2007 (PI)
Mount Sinai Medical Center NIH-NHLBI
1 R01 HL 071988-01A1

SHOCK II Phase 2 Trial
11/01/2003 - 10/30/2005 (PI)
Arginox Pharmaceuticals NIH-NHLBI

Mechanisms Of Pro Thrombosis I
07/01/2001 - 06/30/2005 (PI)
University of Vermont NIH-NHLBI

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

  1. Rymer JA, Kaltenbach LA, Kochar A, Hess CN, Gilchrist IC, Messenger JC, Harrington RA, Jolly SS, Jacobs AK, Abbott JD, Wojdyla DM, Krucoff MW, Rao SV. Comparison of Rates of Bleeding and Vascular Complications Before, During, and After Trial Enrollment in the SAFE-PCI Trial for Women. Circ Cardiovasc Interv. 2019 May; 12(5):e007086. PMID: 31014090.
  2. Hannan EL, Wu Y, Tamis-Holland J, Jacobs AK, Berger PB, Ling FSK, Walford G, Venditti FJ, King SB. Sex differences in the treatment and outcomes of patients hospitalized with ST-elevation myocardial infarction. Catheter Cardiovasc Interv. 2019 Apr 22. PMID: 31012227.
  3. Pande AN, Jacobs AK. Reperfusion and Time to Presentation in Women: Too Little Too Late. J Am Heart Assoc. 2019 Feb 19; 8(4):e011835.View Related Profiles. PMID: 30767600.
  4. Granger CB, Bates ER, Jollis JG, Antman EM, Nichol G, O'Connor RE, Gregory T, Roettig ML, Peng SA, Ellrodt G, Henry TD, French WJ, Jacobs AK. Improving Care of STEMI in the United States 2008 to 2012. J Am Heart Assoc. 2019 Jan 08; 8(1):e008096. PMID: 30596310.
  5. Hannan EL, Zhong Y, Wu Y, Berger PB, Jacobs AK, Walford G, Venditti FJ, Ling FSK, Tamis-Holland J, King SB. Treatment of Coronary Artery Disease and Acute Myocardial Infarction in Hospitals With and Without On-Site Coronary Artery Bypass Graft Surgery. Circ Cardiovasc Interv. 2019 Jan; 12(1):e007097. PMID: 30616362.
  6. Berry NC, Kereiakes DJ, Yeh RW, Steg PG, Cutlip DE, Jacobs AK, Abbott JD, Hsieh WH, Massaro JM, Mauri L. Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women. Circ Cardiovasc Interv. 2018 Aug; 11(8):e005308.View Related Profiles. PMID: 30354781.
  7. Hochberg CP, Jacobs AK. Prehospital delay in patients with ST-segment elevation myocardial infarction: time for change. Coron Artery Dis. 2018 08; 29(5):368-370.View Related Profiles. PMID: 29979256.
  8. Levine GN, Dai X, Henry TD, Calfon Press M, Denktas AE, Garberich RF, Jacobs AK, Jaski BE, Kaul P, Kontos MC, Stouffer GA, Smith SC. In-Hospital ST-Segment Elevation Myocardial Infarction: Improving Diagnosis, Triage, and Treatment. JAMA Cardiol. 2018 Jun 01; 3(6):527-531. PMID: 29466558.
  9. Jacobs AK, Pande AN. Revascularization for Stable Ischemic Heart Disease: The Courage to Use What We Have Learned. JACC Cardiovasc Interv. 2018 May 14; 11(9):876-878.View Related Profiles. PMID: 29747918.
  10. Green JL, Jacobs AK, Holmes D, Chiswell K, Blanco R, Bates ER, French W, Kupas DF, Mears G, Roe M, Nallamothu BK. Taking the Reins on Systems of Care for ST-Segment-Elevation Myocardial Infarction Patients: A Report From the American Heart Association Mission: Lifeline Program. Circ Cardiovasc Interv. 2018 May; 11(5):e005706. PMID: 29716933.
Showing 10 of 400 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 389 publications over 38 distinct years, with a maximum of 28 publications in 2006

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

acute coronary syndromes
angioplasty, percutaneous transluminal
coronary artery disease
Interventional cardiology; Women and heart disease
Contact for Mentoring:

88 E. Newton St Newton Pavilion
Boston MA 02118
Google Map

Jacobs's Networks
Click the "See All" links for more information and interactive visualizations
Similar People
Same Department